E-GEOS: 2025 Net Profit Growth of 5.5% to $41.9 Million, Asia-Pacific Total Revenue Up Approximately 15.7% Year-over-Year

LightningPacketLoss · 2026-03-13T02:30:11+00:00

Yejù Medical released its performance announcement with annual revenue of $180 million in 2025, representing a year-over-year growth of 10%; net profit attributable to shareholders reached $41.9 million, with year-over-year growth of 5.5%. Sales growth in the Asia-Pacific and Europe, Middle East and Africa regions was significant, with year-over-year increases of 15.7% and 19.6%, respectively.

LightningPacketLoss

2026-03-13 02:30:11

Abstract generation in progress

Recently, Yejuyu Medical released its performance report for the fiscal year ending December 31, 2025. The financial summary shows the company’s revenue was $180 million, a 10.0% increase year-over-year; net profit attributable to shareholders was $41.9 million, a 5.5% increase year-over-year; gross profit margin and net profit margin were 67.8% and 23.2%, respectively.

In terms of business performance, sales revenue in the Asia-Pacific region and in Europe, the Middle East, and Africa both saw significant growth. Specifically, the Asia-Pacific region’s total revenue increased approximately 15.7% year-over-year; revenue in Europe, the Middle East, and Africa increased approximately 19.6% year-over-year.

(Yejuyu Medical Announcement)

(Edited by: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.